User: Guest  Login
Title:

Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis.

Document type:
Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Article
Author(s):
Wahn, U; Tabar, A; Kuna, P; Halken, S; Montagut, A; de Beaumont, O; Le Gall, M
Abstract:
BACKGROUND: The efficacy and safety of the 300-index of reactivity (IR) dose of 5-grass-pollen sublingual immunotherapy (SLIT) tablets (Stallergènes, Antony, France) have been demonstrated for the treatment of hay fever in adults. OBJECTIVE: We sought to assess the efficacy and safety of this tablet in children and adolescents with grass pollen-related allergic rhinitis. METHODS: In this multinational, randomized, double-blind, placebo-controlled study, 278 children (5-17 years of age) with gras...     »
Journal title abbreviation:
J Allergy Clin Immunol
Year:
2009
Journal volume:
123
Journal issue:
1
Pages contribution:
160-166.e3
Language:
eng
Fulltext / DOI:
doi:10.1016/j.jaci.2008.10.009
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/19046761
Print-ISSN:
0091-6749
TUM Institution:
Klinik und Poliklinik für Kinderheilkunde und Jugendmedizin
 BibTeX